Syndication Gates Foundation Proniras CSAB Members? Uniformed Services University Reviewed > 4,000 Opportunities Academic & Research Institutions San Diego Office Fund I net IRR of 58.4% WRF Capital Weill Cornell Medicine 2.85 DVPI Operating Partners? Apogen Biotechnologies 1.02 DPI Substantial Exit History 58.43% IRR Case Western Reserve CPRIT Petra Pharma Abbvie Rodeo Therapeutics Lodo Therapeutics 150+ Years’ Experience Turn- Key Facilities ARCH Venture Partners Non- Dilutive Funding Top-tier Investors Seattle Office 2014 Top- quartile Ranked Scientific Expertise Dana Farber Cancer Infectious Disease, Oncology, Microbiome Tachi Yamada, M.D. Leroy Hood, M.D., Ph.D. $3.375 Billion Exit New York Office Steve Gillis, Ph.D. Magnolia Neurosciences Penn State Capital- efficiency Employees Alexandria Venture Investments UT Southwestern Medical Center UT Southwestern Exceptional Track Record AI & Machine Learning Targeted Therapeutic (Asset) Financing $12.3 Million NIDA Grant Harvard Medical School Corporate Spinouts Eli Lilly Oncology Temasek Weill Cornell Medicine Entrepreneurs Strategic Partnerships MD Anderson Cancer Center Divestitures Jan Lundberg, Ph.D. (BARDA) – on updated slide deck Diversity Venture Capital Syndication Partners $1 Billion Genentech Collaboration Neuroscience & Neurology Advisory & Corporate Boards The Rockefeller University WuXi PharmaTech Rodeo Therapeutics Lydian Neurosciences Singapore Office University of Minnesota high-quality, cutting edge life science companies Scientists & Technology Developers Lewis Cantley Lodo Therapeutics Pfizer Ventures Bruce L.A. Carter, Ph.D. Gates Foundation The Rockefeller University Columbia University Sundar Kodiyalam Gene Yeo, Ph.D. Syndication Gates Foundation Proniras CSAB Members? Uniformed Services University Reviewed > 4,000 Opportunities Academic & Research Institutions San Diego Office Fund I net IRR of 58.4% WRF Capital Weill Cornell Medicine 2.85 DVPI Operating Partners? Apogen Biotechnologies 1.02 DPI Substantial Exit History 58.43% IRR Case Western Reserve CPRIT Petra Pharma Abbvie Rodeo Therapeutics Lodo Therapeutics 150+ Years’ Experience Turn- Key Facilities ARCH Venture Partners Non- Dilutive Funding Top-tier Investors Seattle Office 2014 Top- quartile Ranked Scientific Expertise Dana Farber Cancer Infectious Disease, Oncology, Microbiome Tachi Yamada, M.D. Leroy Hood, M.D., Ph.D. $3.375 Billion Exit New York Office Steve Gillis, Ph.D. Magnolia Neurosciences Penn State Capital- efficiency Employees Alexandria Venture Investments UT Southwestern Medical Center UT Southwestern Exceptional Track Record AI & Machine Learning Targeted Therapeutic (Asset) Financing $12.3 Million NIDA Grant Harvard Medical School Corporate Spinouts Eli Lilly Oncology Temasek Weill Cornell Medicine Entrepreneurs Strategic Partnerships MD Anderson Cancer Center Divestitures Jan Lundberg, Ph.D. (BARDA) – on updated slide deck Diversity Venture Capital Syndication Partners $1 Billion Genentech Collaboration Neuroscience & Neurology Advisory & Corporate Boards The Rockefeller University WuXi PharmaTech Rodeo Therapeutics Lydian Neurosciences Singapore Office University of Minnesota high-quality, cutting edge life science companies Scientists & Technology Developers Lewis Cantley Lodo Therapeutics Pfizer Ventures Bruce L.A. Carter, Ph.D. Gates Foundation The Rockefeller University Columbia University Sundar Kodiyalam Gene Yeo, Ph.D.
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Syndication
Gates Foundation
Proniras
CSAB Members?
Uniformed Services University
Reviewed > 4,000 Opportunities
Academic & Research Institutions
San Diego Office
Fund I net IRR of 58.4%
WRF Capital
Weill Cornell Medicine
2.85 DVPI
Operating Partners?
Apogen Biotechnologies
1.02 DPI
Substantial Exit History
58.43% IRR
Case Western Reserve
CPRIT
Petra Pharma
Abbvie
Rodeo Therapeutics
Lodo Therapeutics
150+ Years’ Experience
Turn-Key Facilities
ARCH Venture Partners
Non-Dilutive Funding
Top-tier Investors
Seattle Office
2014 Top-quartile Ranked
Scientific Expertise
Dana Farber Cancer
Infectious Disease, Oncology, Microbiome
Tachi Yamada, M.D.
Leroy Hood, M.D., Ph.D.
$3.375 Billion Exit
New York Office
Steve Gillis, Ph.D.
Magnolia Neurosciences
Penn State
Capital-efficiency
Employees
Alexandria Venture Investments
UT Southwestern Medical Center
UT Southwestern
Exceptional Track Record
AI & Machine Learning
Targeted Therapeutic (Asset) Financing
$12.3 Million NIDA Grant
Harvard Medical School
Corporate Spinouts
Eli Lilly
Oncology
Temasek
Weill Cornell Medicine
Entrepreneurs
Strategic Partnerships
MD Anderson Cancer Center
Divestitures
Jan Lundberg, Ph.D.
(BARDA) – on updated slide deck
Diversity
Venture Capital
Syndication Partners
$1 Billion Genentech Collaboration
Neuroscience & Neurology
Advisory & Corporate Boards
The Rockefeller University
WuXi PharmaTech
Rodeo Therapeutics
Lydian Neurosciences
Singapore Office
University of Minnesota
high-quality, cutting edge life science companies
Scientists & Technology Developers
Lewis Cantley
Lodo Therapeutics
Pfizer Ventures
Bruce L.A. Carter, Ph.D.
Gates Foundation
The Rockefeller University
Columbia University
Sundar Kodiyalam
Gene Yeo, Ph.D.